C
Senior Advisor, Manufacturing Package Design
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company
On-siteDesign
From the original posting
Boston, MA Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological,…
Excerpt from the original posting (English). Full details are on the employer site.m3rad Jobs does not hire and does not represent the employer. The original posting is the reference.